PROCEPT BioRobotics Corporation Operating Cash Flow
PROCEPT BioRobotics Corporation (PRCT) reported Operating Cash Flow of -$57.38 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-05
- PROCEPT BioRobotics Corporation net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$19.25M.
- PROCEPT BioRobotics Corporation net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$38.13M.
- PROCEPT BioRobotics Corporation net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$10.33M.
- PROCEPT BioRobotics Corporation net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$6.63M.
- PROCEPT BioRobotics Corporation net cash provided by (used in) operating activities for fiscal 2025 was -$48.98M.
- PROCEPT BioRobotics Corporation net cash provided by (used in) operating activities for fiscal 2024 was -$99.21M.
- PROCEPT BioRobotics Corporation net cash provided by (used in) operating activities for fiscal 2023 was -$108.00M.
- PROCEPT BioRobotics Corporation net cash provided by (used in) operating activities for fiscal 2022 was -$80.38M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$19.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$57.38M 10-Q · filed 2026-08-05 | -$67.70M derived: sum of 3 quarters · filed 2026-08-05 | -$74.34M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$38.13M 10-Q · filed 2026-04-30 | -$48.45M derived: sum of 2 quarters · filed 2026-04-30 | -$55.09M derived: sum of 3 quarters · filed 2026-04-30 | -$70.13M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$10.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$16.96M derived: sum of 2 quarters · filed 2026-02-26 | -$32.01M derived: sum of 3 quarters · filed 2026-08-05 | -$48.98M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$6.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$21.68M derived: sum of 2 quarters · filed 2026-08-05 | -$38.66M 10-Q · filed 2025-11-05 | -$71.05M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$15.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$32.02M 10-Q · filed 2026-08-05 | -$64.41M derived: sum of 3 quarters · filed 2026-08-05 | -$83.21M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$16.98M 10-Q · filed 2026-04-30 | -$49.37M derived: sum of 2 quarters · filed 2026-04-30 | -$68.17M derived: sum of 3 quarters · filed 2026-04-30 | -$83.91M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | -$32.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$51.19M derived: sum of 2 quarters · filed 2026-02-26 | -$66.93M derived: sum of 3 quarters · filed 2026-02-26 | -$99.21M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$18.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$34.54M derived: sum of 2 quarters · filed 2025-11-05 | -$66.82M 10-Q · filed 2025-11-05 | -$91.61M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$15.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$48.02M 10-Q · filed 2025-08-07 | -$72.81M derived: sum of 3 quarters · filed 2026-02-26 | -$91.76M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$32.29M 10-Q · filed 2025-05-02 | -$57.08M derived: sum of 2 quarters · filed 2026-02-26 | -$76.02M derived: sum of 3 quarters · filed 2026-02-26 | -$104.36M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$24.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$43.74M derived: sum of 2 quarters · filed 2026-02-26 | -$72.08M derived: sum of 3 quarters · filed 2026-02-26 | -$108.00M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$18.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-28 | -$47.28M derived: sum of 2 quarters · filed 2024-10-28 | -$83.21M 10-Q · filed 2024-10-28 | -$108.38M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$28.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | -$64.27M 10-Q · filed 2024-08-02 | -$89.44M derived: sum of 3 quarters · filed 2025-02-27 | -$109.29M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$35.93M 10-Q · filed 2024-05-02 | -$61.10M derived: sum of 2 quarters · filed 2025-02-27 | -$80.95M derived: sum of 3 quarters · filed 2025-02-27 | -$98.08M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$25.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$45.02M derived: sum of 2 quarters · filed 2025-02-27 | -$62.15M derived: sum of 3 quarters · filed 2025-02-27 | -$80.38M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$19.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$36.98M derived: sum of 2 quarters · filed 2023-11-02 | -$55.21M 10-Q · filed 2023-11-02 | -$71.68M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$17.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | -$35.36M 10-Q · filed 2023-07-28 | -$51.83M derived: sum of 3 quarters · filed 2024-02-28 | -$64.58M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$18.23M 10-Q · filed 2023-05-04 | -$34.71M derived: sum of 2 quarters · filed 2024-02-28 | -$47.46M derived: sum of 3 quarters · filed 2024-02-28 | -$60.37M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$16.48M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$29.23M derived: sum of 2 quarters · filed 2024-02-28 | -$42.14M derived: sum of 3 quarters · filed 2024-02-28 | -$57.33M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$12.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$25.66M derived: sum of 2 quarters · filed 2022-11-04 | -$40.86M 10-Q · filed 2022-11-04 | -$54.30M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | -$12.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$28.11M 10-Q · filed 2022-08-05 | -$41.55M derived: sum of 3 quarters · filed 2022-08-05 | |
| 2021-03-31 | -$15.20M 10-Q · filed 2022-05-06 | -$28.64M derived: sum of 2 quarters · filed 2022-05-06 | ||
| 2020-12-31 | -$13.45M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | -$48.34M 10-K · filed 2022-03-22 | ||
| 2020-09-30 | -$34.90M 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |